Moreover, TRAF2 and the cIAPs have recently been identified as major targets facilitating CD8+ T-cell elimination of tumor cells in a TNF-dependent manner in vivo (Vredevoogd et al., 2019). The gene discussed is CD8A; the disease is neoplasm.